Emerging studies suggest Retatrutide , a dual stimulator targeting both GLP-1 and glucose-dependent insulinotropic polypeptide , may offer a promising step forward for weight loss . Preliminary human https://getretatrutideaustralia.com/blog/retatrutide-weight-loss-revolution-2026